Crescita Therapeutics Inc. (TSX:CTX)
Canada
· Delayed Price · Currency is CAD 0.450
0.00 (0.00%)
Mar 6, 2026, 1:29 PM EST
Crescita Therapeutics Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 8 | 11 | 10 | 13 | 14 | 14 | Upgrade
|
| Market Cap Growth | -30.29% | 13.57% | -27.40% | -1.08% | -5.64% | -25.07% | Upgrade
|
| Enterprise Value | 1 | 4 | 1 | 4 | 4 | 2 | Upgrade
|
| Last Close Price | 0.45 | 0.58 | 0.49 | 0.66 | 0.65 | 0.70 | Upgrade
|
| PE Ratio | 22.14 | - | - | 15.65 | - | 390.65 | Upgrade
|
| PS Ratio | 0.38 | 0.57 | 0.56 | 0.57 | 0.81 | 0.92 | Upgrade
|
| PB Ratio | 0.52 | 0.70 | 0.52 | 0.64 | 0.66 | 0.68 | Upgrade
|
| P/TBV Ratio | 0.57 | 0.79 | 0.58 | 0.74 | 0.81 | 0.88 | Upgrade
|
| P/FCF Ratio | 13.45 | 17.71 | 5.04 | - | - | 2.61 | Upgrade
|
| P/OCF Ratio | 4.12 | 4.08 | 4.72 | - | - | 2.58 | Upgrade
|
| EV/Sales Ratio | 0.03 | 0.18 | 0.06 | 0.19 | 0.26 | 0.12 | Upgrade
|
| EV/EBITDA Ratio | 0.92 | - | - | 2.71 | - | 0.92 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 8.26 | - | 2.22 | Upgrade
|
| EV/FCF Ratio | 0.89 | 5.75 | 0.56 | - | - | 0.33 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.05 | 0.07 | 0.08 | 0.14 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.72 | - | - | 0.81 | - | 0.53 | Upgrade
|
| Debt / FCF Ratio | 0.78 | 1.33 | 0.65 | - | - | 0.22 | Upgrade
|
| Net Debt / Equity Ratio | -0.48 | -0.53 | -0.43 | -0.32 | -0.42 | -0.62 | Upgrade
|
| Net Debt / EBITDA Ratio | -31.42 | 3.93 | 9.49 | -4.15 | 17.83 | -6.49 | Upgrade
|
| Net Debt / FCF Ratio | -12.56 | -13.44 | -4.19 | 5.36 | 4.40 | -2.36 | Upgrade
|
| Asset Turnover | 1.00 | 0.84 | 0.66 | 0.82 | 0.60 | 0.58 | Upgrade
|
| Inventory Turnover | 1.85 | 1.96 | 1.22 | 2.06 | 1.72 | 1.21 | Upgrade
|
| Quick Ratio | 2.00 | 1.99 | 2.50 | 2.40 | 2.25 | 3.41 | Upgrade
|
| Current Ratio | 3.12 | 2.78 | 3.80 | 3.39 | 2.99 | 4.21 | Upgrade
|
| Return on Equity (ROE) | 2.83% | -15.87% | -9.95% | 4.14% | -5.30% | 0.18% | Upgrade
|
| Return on Assets (ROA) | -2.21% | -8.32% | -4.61% | 1.15% | -3.35% | 1.94% | Upgrade
|
| Return on Invested Capital (ROIC) | -9.50% | -34.17% | -15.59% | 4.01% | -14.96% | 0.56% | Upgrade
|
| Return on Capital Employed (ROCE) | -4.80% | -19.00% | -9.90% | 2.40% | -6.70% | 3.80% | Upgrade
|
| Earnings Yield | 5.46% | -24.72% | -20.28% | 6.39% | -8.10% | 0.26% | Upgrade
|
| FCF Yield | 7.44% | 5.65% | 19.84% | -9.26% | -14.25% | 38.39% | Upgrade
|
| Buyback Yield / Dilution | 2.70% | 4.44% | 3.55% | -1.18% | 1.02% | 6.79% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.